Launch offer: full deHype evidence reports are £4.99 for a limited time.

Check a headline

Evidence grade

Strong evidence

The claim is broadly supported by relevant human evidence. This means that there are multiple well-designed studies involving people, and the reported effect is reasonably consistent. However, there may still be limitations or context to consider.

Grade meaning:

This grade is used when a claim is broadly supported by relevant human evidence. It suggests that on the balance of available research, the claim is accurate for most people, in most typical circumstances, according to current knowledge.

What does 'strong evidence' mean?

The 'strong evidence' grade indicates:

  • Several well-conducted studies in humans support the claim.
  • The effect has been observed in different groups and settings.
  • The claim does not appear to rely only on animal studies, test-tube experiments, or indirect data.
  • Results are broadly consistent across relevant studies.

Limitations to keep in mind

  • 'Strong evidence' does not mean the effect applies to every person in every situation.
  • Even strong evidence has boundaries: some populations or contexts may be under-researched.
  • Future research could clarify or challenge the current understanding.

How deHype uses this grade

At deHype, this grade is given when there is a good match between a claim and the human research evidence. It reflects a cautious but positive reading of the science, avoiding exaggeration while recognizing substantial support. We do not use this grade for claims based mainly on preliminary, animal, or indirect evidence.

Examples

  • A nutrient deficiency is widely associated with a specific health risk in multiple population studies.
  • A well-studied intervention has shown a consistent beneficial effect in several clinical trials.

Even with a 'strong evidence' grade, keep in mind that science is always evolving. New research can sometimes change what we know.

Reports

Related deHype reports

Specific public claims connected to this topic.

Report · Grade B Evidence check: Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival The article claims that a new targeted therapy—daraxonrasib—for metastatic pancreatic cancer patients with KRAS mutations almost doubles overall survival compared to chemotherapy, based on a phase 3 trial of 500 patients, with secondary claims that this represents a paradigm shift, offering improved quality of life and milder side-effects versus standard care. Report · Grade C Evidence check: Why some brain cells are particularly vulnerable to multiple sclerosis The article describes new research identifying that a specific set of brain cells (CUX2 neurons) are especially susceptible to dying in the context of progressive multiple sclerosis because DNA damage caused by inflammation exceeds their ability to repair themselves. The research involved both human postmortem tissue from MS patients and mouse models where DNA repair proteins (notably ATF4) were experimentally disabled, aggravating neuron loss. The findings suggest that, beyond the traditionally-recognized loss of myelin, intrinsic neuronal vulnerability and impaired DNA repair are critical in the neurodegenerative progression of MS. This opens the possibility of future therapies aimed at protecting these neurons but has not established any immediate treatment or clinical recommendations.

Helpful evidence guides

How deHype grades claims Learn how deHype evaluates health and science claims with a transparent grading system based on strength, relevance, and quality of evidence. How to read a health headline A practical guide to spotting overstatement and understanding the evidence behind health and science headlines.

Related grade pages

Not clinically actionable This grade is used for findings where the evidence is not yet strong or direct enough to support changes to clinical practice or personal health decisions. Not human evidence This grade means that the claim is based on evidence from non-human studies, such as animal experiments or cell cultures. These findings are important for scientific research, but they do not show proven effects in humans. Overstated The claim goes beyond what the underlying evidence supports. Promising but early The evidence is interesting but not mature enough for strong practical claims. Findings may show initial promise, but more research is needed before health recommendations can be made.
Seen a headline in this area? Paste the link and get a deHype evidence check.
Check a headline